PGHL — Procter & Gamble Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapHigh Flyer

Annual income statement for Procter & Gamble Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	9 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	11,144	12,296	11,513	9,342	14,080
Cost of Revenue
Gross Profit	6,888	7,824	7,425	6,167	9,461
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	8,733	9,330	8,929	6,325	9,730
Operating Profit	2,411	2,966	2,584	3,017	4,349
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,534	3,142	2,733	3,116	4,499
Provision for Income Taxes
Net Income After Taxes	1,925	2,295	2,010	2,344	3,269
Net Income Before Extraordinary Items
Net Income	1,925	2,295	2,010	2,344	3,269
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,925	2,295	2,010	2,344	3,269
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	119	143	131	142	198
Dividends per Share
Special Dividends per Share